Trial
NCT01375816
Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Collaborators
—
Condition
Colorectal Cancer
Intervention
FOLFIRI 1-Bevacizumab
Why stopped
efficacy interim analysis as per protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-04